Evidence map›Paper›PMID 41346305›Full record

ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2026

NADH-Reductive Stress Induced by Dihydrolipoamide Dehydrogenase Activation Contributes to Cuproptosis.

Si-Yi Zhang, Xing-Hua Ren, Cheng-Hong Zhang, Zhan-You Wang

Abstract read
In one paragraph

Article in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Si-Yi ZhangKey Laboratory of Medical Cell Biology of Ministry of Education, Key Laboratory of Major Chronic Diseases of Nervous System of Liaoning Province, Health Sciences Institute of China Medical University, Shenyang, 110122, China.ORCID https://orcid.org/0000-0003-1944-7358
Xing-Hua RenSchool of Forensic Medicine, China Medical University, Shenyang, 110122, China.ORCID https://orcid.org/0000-0003-0106-0702
Cheng-Hong ZhangBasic Medical Experimental Teaching Center, China Medical University, Shenyang, 110122, China.
Zhan-You WangKey Laboratory of Medical Cell Biology of Ministry of Education, Key Laboratory of Major Chronic Diseases of Nervous System of Liaoning Province, Health Sciences Institute of China Medical University, Shenyang, 110122, China.ORCID https://orcid.org/0000-0003-0807-9916

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Copper (Cu) is an essential trace element for cellular metabolism, while excessive Cu accumulation leads to neurotoxicity. Current therapeutic strategies for Cu overload remain inadequate in mitigating neurological symptoms. The recently discovered Cu-dependent mitochondrial cell death pathway, cuproptosis, offers novel insights into Cu-mediated neurotoxicity. In this study, the mechanistic link between mitochondrial respiration and cuproptosis is elucidated. The current study demonstrates that activated dihydrolipoamide dehydrogenase (DLD), induced by excess Cu under alkaline mitochondrial pH conditions, drives nicotinamide adenine dinucleotide (NADH) accumulation. Cu mediated mitochondrial permeability transition pore (mPTP) opening that facilitates NADH translocation to the cytosol, triggering NADH-reductive stress. This promotes aberrant purine biosynthesis, leading to severe adenosine triphosphate depletion and energy stress. Pharmacological interventions targeting DLD activity, cytosolic NADH, mPTP opening, purine biosynthesis, or energy stress effectively rescued Cu-induced cell death in SH-SY5Y neuroblastoma cells. Collectively, these findings reveal characteristics of NADH-reductive stress under excessive Cu exposure, establishing cuproptosis as a novel NADH-reductive stress-dependent cell death pathway. This mechanistic insight provides new therapeutic avenues for Cu-associated neurological pathologies and new aspects to explore Cu cellular physiology.

Indexed as

CopperDihydrolipoamide DehydrogenaseNADCell Line, TumorHumansMitochondriaCopperDihydrolipoamide DehydrogenaseNADcoppercuproptosisdihydrolipoamide dehydrogenasemitochondrial permeability transition poreNADH‐reductive stress

Identifiers

PMID41346305
PMCPMC12904017

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.